Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPerimeter Medical Imaging AI Inc

Perimeter Medical Imaging AI Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.18 CAD 0.00(0%)
Last update at 2026-11-04T20:08:00Z
VOLUME
367050
Market Cap
43.27M
P/E
4.13

Momentum Score

…

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging solutions to address unmet medical needs. The company offers the Perimeter S-Series optical coherence tomography (OCT) imaging system, which delivers high-resolution margin visualization of excised tissue specimens in the operating room. It is also developing the Perimeter B-Series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company provides a proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.16
Low
0.18
High
52 Week Price Range
0.17
Low
0.72
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Perimeter Medical Imaging AI Inc develops high-resolution intraoperative imaging systems and AI software intended to assess surgical tissue margins in real time for cancer procedures. Long-term growth drivers include demand to reduce re-excision rates, wider adoption of point-of-care pathology tools, and potential regulatory approvals and reimbursement expansion. The company may benefit from a focused clinical niche and appears positioned to support more efficient surgical decision-making.

Key risks include limited commercial traction and revenue to date, regulatory and reimbursement uncertainty, execution and scaling challenges for clinical adoption, and financing and liquidity constraints common to small-cap medical device firms.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.18
Dividend Yield
-
Revenue TTM
2.30M
Revenue Per Share
0.03
Gross Profit TTM
1.85M
Debt / Equity
0.01
ROE
-177.15%
Net Debt
-18.18M
ROCE
-173.99%
Diluted EPS TTM
0.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -13.39M -18.94M -9.91M -16.65M -7.89M
Net income -13.39M -18.94M -9.91M -16.65M -7.89M
Selling general administrative 12.23M 6.12M 10.28M 11.56M 8.96M
Selling and marketing expenses - 4.96M - - -
Gross profit 0.54M -0.36M 0.10M 0.01M -
Reconciled depreciation 0.73M 0.61M 0.80M 0.09M 0.05M
Ebit - -22.27M - - -10.06M
Ebitda - -21.44M -9.00M -16.45M -7.74M
Depreciation and amortization - 0.83M - - -
Operating income -18.71M -22.27M -16.12M -16.06M -10.06M
Other operating expenses - 22.82M - - 0.48M
Interest expense 0.03M 0.14M 0.10M 0.11M 0.12M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - - - 0.01M 0.01M
Net interest income 0.27M 0.58M -0.10M -0.10M -1.72M
Income tax expense - 0.00M - - -
Total revenue 0.85M 0.54M 0.13M 0.01M 0.00M
Total operating expenses 19.55M 21.91M 16.25M 16.07M 10.06M
Cost of revenue 0.31M 0.90M 0.03M 0.01M -
Total other income expense net 5.04M 3.33M 6.32M -0.49M 3.90M
Net income from continuing ops -13.39M -14.04M -9.91M -16.65M -7.89M
Net income applicable to common shares - - - - -7.89M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 14.33M 27.09M 34.60M 9.98M 13.16M
Other current assets - 1.48M - - -
Total liab 3.87M 7.10M 8.49M 2.56M 2.40M
Total stockholder equity 10.45M 19.86M 26.11M 7.42M 10.76M
Other current liab 0.05M 4.57M 6.04M - 0.52M
Common stock - 107.89M - - 48.50M
Capital stock 90.60M 81.82M 80.84M 62.47M 48.50M
Retained earnings -86.75M -96.73M -59.32M -63.98M -47.33M
Other liab - - - - 0.27M
Cash 6.18M 18.43M 28.44M 4.72M 10.03M
Total current liabilities 3.58M 6.91M 8.04M 2.15M 1.82M
Current deferred revenue - 0.05M - - -
Net debt - -18.18M - - -
Short term debt - 0.07M - - -
Short long term debt - - 0.11M 0.13M 0.05M
Short long term debt total - 0.25M - - -
Other stockholder equity - 10.07M - - 0.18M
Property plant equipment - - - - 0.08M
Total current assets 9.97M 23.18M 31.50M 7.74M 13.07M
Net tangible assets - - - - 10.76M
Short term investments - - 0.00M 0.42M 1.67M
Net receivables 0.39M 3.10M 0.07M - 0.60M
Long term debt - - 0.01M 0.16M 0.29M
Inventory 0.19M 0.17M 0.04M 0.01M -
Accounts payable - 2.22M - - 1.21M
Accumulated other comprehensive income - -1.36M - - -
Non currrent assets other 0.00M - - - -
Non current assets total 4.36M 3.90M 3.10M 2.25M 0.09M
Capital lease obligations 0.14M 0.19M 0.21M 0.15M 0.06M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.90M 0.21M -1.75M -1.45M 6.33M
Change to liabilities - - 0.00M -0.91M -0.16M
Total cashflows from investing activities - - - - 7.24M
Net borrowings -0.07M -0.28M - - -0.14M
Total cash from financing activities 8.58M 0.32M 40.28M 10.06M 9.84M
Change to operating activities - - - -0.49M -0.51M
Net income -13.39M -18.94M -9.91M -16.65M -7.89M
Change in cash -8.04M -20.10M 26.67M -5.31M 8.81M
Begin period cash flow 13.98M 38.53M 3.72M 10.03M 1.21M
End period cash flow 6.18M 18.43M 28.44M 4.72M 10.03M
Total cash from operating activities -14.72M -19.84M -11.87M -13.91M -8.26M
Issuance of capital stock 8.65M 0.00M 38.14M 0.00M 9.41M
Depreciation 0.73M 0.83M 0.80M 0.09M 0.05M
Change to inventory -0.06M -0.12M -0.04M -0.01M -
Change to account receivables -0.35M -0.44M -0.07M 0.27M -0.26M
Other cashflows from financing activities - 0.28M 0.42M 0.42M 1.62M
Change to netincome - - - - 0.50M
Capital expenditures 2.18M 0.64M 1.99M 2.12M 0.00M
Change in working capital 1.80M -0.77M -0.23M 0.41M -0.94M
Stock based compensation 1.90M 1.46M 1.52M 3.13M 2.25M
Other non cash items -0.42M 1.27M -2.51M -0.90M -1.84M
Free cash flow -16.90M -20.48M -13.86M -16.03M -8.26M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PINK
Perimeter Medical Imaging AI Inc		 -
-%		 0.18 4.13 - 18.78 11.34 20.22 -2.55
TLT
Theralase Technologies Inc.		 0.01
2.78%		 0.18 - - 90.07 82.51 90.31 -12.06
CNVI
Conavi Medical Corp.		 -0.01
4.55%		 0.10 - - 66.65 - 95.30 -
CHER
Cheelcare Inc.		 -
-%		 1.25 - - 20.92 106.42 21.26 -
ASG
Aurora Spine Corp		 -0.01
13.04%		 0.10 - - 1.19 4.07 1.02 202.96

Profile*

Perimeter Medical Imaging AI Inc

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging solutions to address unmet medical needs. The company offers the Perimeter S-Series optical coherence tomography (OCT) imaging system, which delivers high-resolution margin visualization of excised tissue specimens in the operating room. It is also developing the Perimeter B-Series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company provides a proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.

555 Richmond Street West, Toronto, ON, Canada, M5V 3B1

214-845-5154

https://perimetermed.com

Name Title Year Born
Mr. Jeremy Sobotta CEO, Pres & Director NA
Mr. Merle Thomas Boon Chief Operating Officer NA
Mr. Andrew Berkeley Co-Founder & Head of Bus. Devel. NA
Mr. Christopher K. Scott Chief Financial Officer 1970
Mr. Vladimir Pekar Head of AI Algorithm Devel. NA
Ms. Rochelle Keen Head of Clinical Research Programs NA
Mr. Steve Sapot Chief Commercial Officer NA
Mr. Adrian Mendes CEO & Director NA
Mr. Andrew Berkeley Co-Founder & Chief Innovation Officer NA
Ms. Sara Brien Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…